Furthermore, an in vivo study showed that MitoTempo reduced hypertension in two murine models of hypertension, namely, angiotensin II-induced hypertension and DOCA-salt hypertension, in part by decreasing vascular ROS concentrations and increasing NO production, with the consequent improvement in endothelial relaxation and vascular tone (201). Here, AGT is linked to Hypertension.